The law offices of frank r. cruz announces investigation of ampio pharmaceuticals, inc. (ampe) on behalf of investors

Los angeles--(business wire)--the law offices of frank r. cruz announces an investigation of ampio pharmaceuticals, inc. (“ampio” or the “company”) (nyse american: ampe) on behalf of investors concerning the company's possible violations of federal securities laws. if you are a shareholder who suffered a loss, click here to participate. on april 20, 2022, ampio announced that the u.s. food and drug administration (“fda”) responded negatively to its type c meeting request for the company's ap-01
AMPE Ratings Summary
AMPE Quant Ranking